Support PenkeNeurocrine Biosciences Inc - Trending symbols
Latest News of Neurocrine Biosciences Inc
| Date | Title | Read |
|---|---|---|
| 2025-05-07 09:34 | Why Neurocrine Biosciences, Inc. (NBIX) Skyrocketed On Tuesday | Read |
| 2025-05-06 18:55 | Stocks making the biggest moves midday: Palantir, Tesla, DoorDash, Ford and more | Read |
| 2025-05-05 23:12 | Stocks making the biggest moves after hours: Palantir Technologies, Ford Motor, Mattel, Clorox and more | Read |
| 2025-04-14 22:01 | Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results | Read |
| 2025-04-09 13:00 | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals. | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-05-07 |
Trends
| 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Retained Earnings | -304,800 | 147,700 | -157,100 | 43,400 | -113,700 | 65,000 | -48,700 | 129,800 | 81,100 | |
| Accumulated Other Comprehensive Income | -7,900 | 5,200 | -2,700 | 1,600 | -1,100 | -600 | -1,700 | 8,700 | 7,000 | |
| Net Debt | 53,600 | 115,800 | 169,400 | 180,900 | 350,300 | -251,700 | 98,600 | -136,500 | -37,900 | |
| Total Other Income Expense Net | 10,100 | 4,400 | 14,500 | -3,600 | 10,900 | 38,400 | 49,300 | -73,800 | -24,500 | |
| EBIT | 3,100 | 51,600 | 54,700 | 33,100 | 87,800 | 11,200 | 99,000 | -213,200 | -114,200 | |
| Operating Income | 3,100 | 51,600 | 54,700 | 33,100 | 87,800 | 15,600 | 103,400 | -217,600 | -114,200 | |
| Cash And Cash Equivalents | 270,200 | -106,900 | 163,300 | 48,900 | 212,200 | 50,700 | 262,900 | -353,300 | -90,400 | |
| Other Stockholders Equity | 1,947,700 | 52,100 | 1,999,800 | 54,500 | 2,054,300 | 68,100 | 2,122,400 | -2,125,100 | -2,700 | |
| Income before Tax | 41,700 | -14,500 | 27,200 | 30,300 | 57,500 | -27,000 | 30,500 | -44,300 | -13,800 | |
| Net Income | 347,900 | -315,800 | 32,100 | 10,200 | 42,300 | -19,800 | 22,500 | -29,800 | -7,300 | |
| EBITDA | 51,700 | -15,600 | 36,100 | 30,200 | 66,300 | -26,400 | 39,900 | -44,100 | -4,200 | |
| Net Income from Continuing Operations | 347,900 | -315,800 | 32,100 | 10,200 | 42,300 | -19,800 | 22,500 | -29,800 | -7,300 | |
| Net Income Applicable to Common Shares | 347,900 | -315,800 | 32,100 | 10,200 | 42,300 | -19,800 | 22,500 | -29,800 | -7,300 |
Comments
How you think about this?